Metronidazole dental gel as an alternative to scaling and root planing in the treatment of localized adult periodontitis. Is its efficacy proved?

European Journal of Oral Sciences

Volumn 107, Issue 6, 1999, Pages 415-421

  Knoll Köhler, Elisabeth ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Metronidazole local; Periodontitis; Randomized trial

Indexed keywords

ACYLGLYCEROL; DRUG DERIVATIVE; ELYZOL DENTALGEL; METRONIDAZOLE; SESAME SEED OIL; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PERITONITIS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SINGLE BLIND PROCEDURE;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; DENTAL SCALING; FEMALE; GLYCERIDES; HUMANS; MALE; METRONIDAZOLE; OUTCOME ASSESSMENT (HEALTH CARE); PERITONITIS; REPRODUCIBILITY OF RESULTS; SESAME OIL; SINGLE-BLIND METHOD;

EID: 0033258127     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1046/j.0909-8836.1999.eos107601.x     Document Type: Article

References (47)

1. SOCRANSKY S, HAFFAJEE A. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992; 63: 322-331.
2. HAFFAJEE A, SOCRANSKY S. Microbial etiological agents of destructive periodontal disease. Periodontol 2000 1994; 5: 78-111.
3. BECK J, KOCH G, ROZIER R, TUDOR G. Prevalence and risk indicators for periodontal attachment loss in a population of older community-dwelling blacks and whites. J Periodontol 1990; 61: 521-528.
4. VAN DYKE T, LESTER M, SHAPIRA L. The role of host response in periodontal disease progression: implications for future treatment strategies. J Periodontol 1993; 64: 792-806.
5. WHEELER T, MCARTHUR W, MAGNUSSON I, MARKS R, SMITH J, SARRETT D, BENDER B, CLARK W. Modeling the relationship between clinical, microbiologic, and immunologic parameters and alveolar bone levels in an elderly population. J Periodontol 1994; 65: 68-78.
6. OFFENBACHER S. Periodontal diseases: pathogenesis. Ann Periodontol 1996; 1: 879-925.
7. WASSENAAR A, REINHARDUS C, ABRAHAM-INPIJN L, SNIJDERS A, KIEVITS F. Characteristics of prevotella intermedia-specific CD4+ T cell clones from peripheral blood of a chronic adult periodontitis patient. Clin Exp Immunol 1998; 113: 105-110.
8. SHAPIRA L, CHAMPAGNE C, VAN DYKE T, AMAR S. Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of porphyromonas gingivalis. Infect Immun 1998; 66: 2736-2742.
9. SHAPIRA L, VAN DYKE T, HART T. A localized absence of interleukin-4 triggers periodontal disease activity: a novel hypothesis. Med Hypotheses 1992; 39: 319-322.
10. SALVI G, BECK J, OFFENBACHER S. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998; 3: 40-50.
11. PABST M, PABST K, COLLIER J, COLEMAN T, LEMONS-PRINCE M, GODAT M, WARING M, BABU J. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 1995; 66: 1047-1055.
12. PAYNE J, JOHNSON G, REINHARDT R, DYER J, MAZE C, DUNNING D. Nicotine effects on PGE2 and IL-1 beta release by LPS-treated human monocytes. J Periodontol Res 1996; 31: 99-104.
13. SLOTS J, RAMS TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodont 1990; 17: 479-493.
14. ADDY M, RAWLE L, HANDLEY R, NEWMAN HN, COVENTRY JF. The development and in vitro evaluation of acrylic strips and dialysis tubing for local drug delivery. J Periodontol 1982; 53: 693-699.
15. FRIEDMAN M, GOLOMB G. New sustained release dosage form of chlorhexidine for dental use. J Periodontol Res 1982; 17: 323-328.
16. COVENTRY J, NEWMAN H. Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation. J Clin Periodontol 1982; 9: 129-133.
17. GOODSON J, HOLBOROW D, DUNN R, HOGAN P, DUNHAM S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983; 54: 575-579.
18. STEINBERG D, FRIEDMAN M, SOSKOLNE A, SELA M. A new degradable controlled release device for treatment of periodontal disease: In vitro release study. J Periodontol 1990; 61: 393-398.
19. STOLZE K, STELLFELD M. Systemic absorption of metronidazole after application of a metronidazole 25% dental gel. J Clin Periodontol 1992; 19: 693-697.
20. STOLZE K. Concentration of metronidazole in periodontal pockets after application of a metronidazole 25% dental gel. J Clin Periodontol 1992; 19: 698-701.
21. AWARTANI F, ZULQARNAIN B. Comparison of the clinical effects of subgingival application of metronidazole 25% gel and scaling in the treatment of adult peridontitis. Quintessence Int 1998; 29: 41-48.
22. LIE T, BRUUN G, BŌE O. Effects of topical metronidazole and tetracycline in the treatment of adult periodontitis. J Periodontol 1998; 69: 819-827.
23. AINAMO J, LIE T, ELLINGSEN B, HANSEN B, JOHANSSON L, KARRING T, KISCH J, PAUNIO K, STOLTZE K. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis. J Clin Periodontol 1992; 19: 723-729.
24. KLINGE B, ATTSTRÖM R, KARRING T, KISCH J, LEWIN B, STOLZE K. 3 regimens of topical metronidazole compared with subgingival scaling on periodontal pathology in adults. J Clin Periodontol 1992; 19: 708-714.
25. PEDRAZZOLI V, KILIAN M, KARRING T. Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis. J Clin Periodontol 1992; 19: 715-722.
26. STELZEL M, FLORES-DE-JACOBY L. Topical metronidazol application in recall patients. Long-term results. J Clin Periodontol 1997; 24: 914-919.
27. STELZEL M, FLORES-DE-JACOBY L. Topical metronidazole application compared with subgingival scaling. J Clin Periodontol 1996; 23: 24-29.
28. RUDHART A, PURUCKER P, KAGE A, HOPFENMÜLLER W, BERNIMOULIN J-P. Local metronidazole application in maintenance patients. Clinical and microbiological evaluation. J Periodontol 1998; 69: 1148-1154.
29. LOESCHE W, SCHMIDT E, SMITH B, CAFFESSEE R, STOLL J. Metronidazole therapy for periodontitis. J Periodontol Res 1987; 22: 224-226.
30. ANTCZAK A, TANG J, CHALMERS T. Quality assessment of randomized control trials in dental research. I. Methods. J Periodont Res 1986; 21: 305-311.
31. BEGG C, CHO M, EASTWOOD S, HORTON R, MOHER D, OLKIN I, PITKIN R, RENNIE D, SCULZ K, SIMEL D, STROUP D. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. J Am Med Assoc 1996; 276: 637-639.
32. DYER JK, PECK MA, REINHARDT RA, DUCKWORTH WC, BOOTH SJ, SEYMOUR GJ, PATIL KD. HLA-D types and serum IgG responses to Capnocytophaga in diabetes and periodontitis. J Dent Res 1997; 76: 1825-1832.
33. BOSTRÖM L, LINDER LE, BERGSTRÖM J. Clinical expression of TNF-α in smoking-associated periodontal disease. J Clin Periodontol 1998; 25: 767-773.
34. BOUCLIN R, LANDRY R, NOREAU G. The effects of smoking on periodontal structures: a literature review. J Can Dent Assoc 1997; 356: 360-363.
35. REINHARDT RA, PAYNE JB, MAZE C, BABBITT N, NUMMIKOSKI PV, DUNNING D. Gingival fluid IL-1β in post-menopausal females on supportive periodontal therapy. J Clin Periodontol 1998; 25: 1029-1035.
36. PACIFICI R, RIFAS I, MCCRACKEN R. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release. Proc Natl Acad Sci USA 1989; 86: 2398-402.
37. COHEN-SOLAL ME, GRAULET AM, DENNE MA, GUERIS J, BAYLINK D, DE VERNEJOUL MC. Peripheral blood monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 1993; 77: 1648-1653.
38. ARMITAGE GC. Clinical evaluation of periodontal diseases. Periodontol 2000 1995; 7: 39-53.
39. Consensus report non-surgical pocket therapy: mechanical, pharmacotherapeutics, and dental occlusion. Ann Periodontol 1996; 1: 581-588.
40. Consensus report. Position Paper: Supportive periodontal therapy. J Periodontol 1998; 69: 502-505.
41. DONNER A, BROWN KS, BRASHER P. A methodological review of nontherapeutic intervention trials employing cluster randomization, 1979-1989. Int J Epidemiol 1990; 19: 795-800.
42. SCHULZ KF, CHALMERS I, HAYES RJ, ALTMAN DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
43. XU X, STEWART P, CHEN X. Transport limitation of chlorine desinfection of Pseudomonas aeruginosa entrapped in alginate beads. Biotechnol Bioeng 1996; 49: 93-100.
44. TRESSE O, JOUENNE T, JUNTER G-A. The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics. J Antimicrob Chemother 1995; 36: 521-526.
45. TRESSE O, JOUENNE T, JUNTER G-A. Underexpression of porin protein OmpF in agar-entrapped, sessile-like Escherichia coli. Antonie van Leeuwenhoek J Microbiol Serol 1997; 72: 271-274.
46. GOODMAN A, MARSHALL K. Genetic responses of bacteria at surfaces. In: LAPPIN-SCOTT HM, COSTERTON JW, eds. Microbial Biofilms. Cambridge: Cambridge University Press, 1995; 80-98.
47. COQUET L, JUNTER G, JOUENNE T. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. J Antimicrob Chemother 1998; 42: 755-760.